Integrated BioPharma (INBP) Net Income by Year
Integrated BioPharma Inc reported a net loss of $2.8M in fiscal year 2026. This represents a decrease of 451.7% from the prior fiscal year. The table below carries 15 fiscal years, from 2012 to 2026, and the quarters Integrated BioPharma Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
INBP Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
INBP Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Integrated BioPharma Inc financials
Frequently Asked Questions
Integrated BioPharma Inc reported a net loss of $2.8M in fiscal year 2026.
Integrated BioPharma Inc (INBP) net income fell by 451.7% year over year, from $808K to -$2.8M in fiscal year 2026.
Across the 15 fiscal years this page covers, Integrated BioPharma Inc (INBP) net income went from -$2.7M in fiscal year 2012 to -$2.8M in fiscal year 2026.
Integrated BioPharma Inc (INBP) reported -$1.4M in net income in Q4 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Integrated BioPharma Inc (INBP) reported on that line in every period on record.